Market Tracker

11/22 9:52am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.61
Delayed Data
As of 9:30am ET
 -0.009 / -0.56%
Today’s Change
1.55
Today|||52-Week Range
5.70
-7.41%
Year-to-Date

Today’s Trading

Previous close1.62
Today’s open1.59
Day’s range1.59 - 1.61
Volume3,429
Average volume (3 months)156,713
Market cap$25.3M
Dividend yield--
Data as of 9:30am ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-436.90%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.42

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.06+0.80%
PPHMPPeregrine Pharmaceut...0.000.00%
PULMPulmatrix Inc+0.01+0.66%
PRPHProPhase Labs Inc0.000.00%
Data as of 9:37am ET, 11/22/2017

Financials

Last reporting dateNovember 13, 2017
EPS forecast (this quarter)-$2.13
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts